ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,352.96
      -0.02%
      US Tech 100
      18,548.00
      0.04%
      Dow Jones
      38,886.17
      0.20%
      Brent Oil
      79.88
      1.68%
      Bitcoin
      70,815.99
      -0.37%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Valneva SE (VLA)

      7. Valneva SE (VLA) News

      VLA

      Valneva (VLA)

      Valneva SE
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:VLA
      DateTimeSourceHeadlineSymbolCompany
      06/05/20241:00AMGlobeNewswire Inc.Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de directionEU:VLAValneva SE
      06/05/20241:00AMGlobeNewswire Inc.Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate UpdateEU:VLAValneva SE
      06/05/20241:00AMGlobeNewswire Inc.Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate UpdateEU:VLAValneva SE
      06/04/202412:00PMGlobeNewswire Inc.VALNEVA - Declaration of shares and voting rights: May 31, 2024EU:VLAValneva SE
      06/04/202412:00PMGlobeNewswire Inc.VALNEVA - Déclaration d’actions et de droits de vote : 31 mai 2024EU:VLAValneva SE
      06/04/202411:35AMGlobeNewswire Inc.Valneva to Present and Hold Investor Meetings at Upcoming Conferences in JuneEU:VLAValneva SE
      06/04/202411:35AMGlobeNewswire Inc.Valneva to Present and Hold Investor Meetings at Upcoming Conferences in JuneEU:VLAValneva SE
      06/04/202411:35AMGlobeNewswire Inc.Valneva annonce sa participation à différentes conférences investisseurs du mois de juinEU:VLAValneva SE
      06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesEU:VLAValneva SE
      06/03/202411:35AMGlobeNewswire Inc.Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious DiseasesEU:VLAValneva SE
      06/03/202411:35AMGlobeNewswire Inc.Valneva annonce la publication de deux essais de Phase 2 sur la maladie de Lyme dans le Lancet Infectious DiseasesEU:VLAValneva SE
      05/31/202411:35AMGlobeNewswire Inc.Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya VaccineEU:VLAValneva SE
      05/31/202411:35AMGlobeNewswire Inc.Valneva reçoit un avis positif du CHMP pour une autorisation de mise sur le marché en Europe de son vaccin contre le chikungunyaEU:VLAValneva SE
      05/31/202411:35AMGlobeNewswire Inc.Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya VaccineEU:VLAValneva SE
      05/21/20241:00AMGlobeNewswire Inc.Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific OfficerEU:VLAValneva SE
      05/21/20241:00AMGlobeNewswire Inc.Valneva annonce la nomination du Dr Hanneke Schuitemaker en tant que Directeur ScientifiqueEU:VLAValneva SE
      05/21/20241:00AMGlobeNewswire Inc.Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific OfficerEU:VLAValneva SE
      05/13/20241:00AMGlobeNewswire Inc.Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunyaEU:VLAValneva SE
      05/13/20241:00AMGlobeNewswire Inc.Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineEU:VLAValneva SE
      05/13/20241:00AMGlobeNewswire Inc.Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineEU:VLAValneva SE
      05/07/20241:00AMGlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesEU:VLAValneva SE
      05/07/20241:00AMGlobeNewswire Inc.Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activitésEU:VLAValneva SE
      05/07/20241:00AMGlobeNewswire Inc.Valneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesEU:VLAValneva SE
      05/06/20241:30AMGlobeNewswire Inc.Declaration of shares and voting rights April 30, 2024 - VALNEVA SEEU:VLAValneva SE
      05/06/20241:30AMGlobeNewswire Inc.Déclaration d’actions et de droits de vote - 30 avril 2024 - Valneva SEEU:VLAValneva SE
      04/04/202412:00PMGlobeNewswire Inc.Déclaration d'actions et de droits de vote de la société Valneva SE - mars 2024EU:VLAValneva SE
      04/04/202412:00PMGlobeNewswire Inc.Declaration of voting rights - Valneva SE, March 2024EU:VLAValneva SE
      03/26/20242:00AMGlobeNewswire Inc.Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine CandidateEU:VLAValneva SE
      03/26/20242:00AMGlobeNewswire Inc.Valneva lance un essai de Phase 1 sur son candidat vaccin de deuxième génération contre le virus ZikaEU:VLAValneva SE
      03/26/20242:00AMGlobeNewswire Inc.Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine CandidateEU:VLAValneva SE
       Showing the most relevant articles for your search:EU:VLA